Clinical Trials and Research

CanSinoBIO Advances Five-Component Pertussis Booster Vaccine in China

Pertussis is a highly contagious acute respiratory infectious disease caused by Bordetella pertussis...

Everest Medicines Announces NMPA Acceptance of BLA for LEROCHOL(R)

The on-schedule acceptance underscores the Company's disciplined execution of its clinical and regulatory strategy...

Ascendis Pharma’s Combination Therapy Shows Durable Growth in Children with Achondroplasia

Treatment with the combination of once-weekly TransCon CNP and once-weekly TransCon hGH continued to demonstrate durable growth in children with achondroplasia...

Pusan National University Introduces ASTRA-Net for Improved Lung Airway Mapping

ASTRA-Net helps reconstruct overlooked peripheral airways, creating more complete maps for bronchoscopy procedures...

QIMR Berghofer and JCU Expand Collaboration on Tropical Health Research

The partnership will be driven through collaboration between JCU’s Australian Institute of Tropical Health and Medicine (AITHM) and QIMR Berghofer’s Centre for Tropical Health and Emerging Diseases (CTHED)...

Invenio Imaging Completes US Pivotal Study of AI-Powered Lung Biopsy Analysis

The study collected more than 3,250 fresh biopsy specimens across seven medical centers...

SCRI Marks 30 Years with Clinical Trials Symposium 2026 in Singapore

SCRI and its parent company, the Consortium of Clinical Research and Innovation (CRIS), signed three Memoranda of Understanding (MOUs) with eight key public and private sector partners...

Waters Launches Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

Brings Xevo TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology ...

OrbusNeich Announces Enrollment of First Patient in Japan Clinical Trial for its Proprietary Drug-Coated Balloon

This trial will evaluate the Group’s proprietary coronary paclitaxel drug-coated balloon (DCB)...

NTU Singapore-led Study Identifies New Mechanism Behind Cancer Resistance to PARP Inhibitors

The international research team found that resistant cancer cells can hijack a specific DNA repair defence mechanism to protect themselves from the effects of PARP inhibitors...